BBOT Smart Money
BridgeBio Oncology Therapeutics Inc.
1W: -1.1%
1M: -29.4%
3M: -67.3%
YTD: -78.1%
1Y: -75.5%
$2.69
+0.05 (+1.89%)
Pre-Market: $2.78 (+0.09, +3.35%)
Weekly Expected Move ±8.7%
$2
$2
$3
$3
$3
Credit Risk of going bust: lower than 64% of companies Debt: 1.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.8%), BridgeBio Oncology Therapeutics Inc. would be worth roughly what it owes.
Total debt $2.5M against a stock market value of $215.7M.
Distance to default 6.68 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.5M (short-term plus half of long-term), stock volatility 71.5%; Altman Z'' 2.23. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 99.8%), BridgeBio Oncology Therapeutics Inc. would be worth roughly what it owes.
Total debt $2.5M against a stock market value of $215.7M.
Distance to default 6.68 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.5M (short-term plus half of long-term), stock volatility 71.5%; Altman Z'' 2.23. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-21 | Cobo Marc | officer: principal accounting officer | F-Tax Withholding | 203 | $2.68 | $544 | Filing |
| 2026-10-01 | Ben Yong | officer: chief med & dev officer | F-Tax Withholding | 1,047 | $3.94 | $4K | Filing |
| 2026-10-01 | Beltran Pedro | officer: president and ceo | F-Tax Withholding | 1,047 | $3.94 | $4K | Filing |
| 2026-10-01 | Elmelech Idan | officer: coo & principal financial ofcr | F-Tax Withholding | 343 | $3.94 | $1K | Filing |
| 2026-10-01 | Cobo Marc | officer: principal accounting officer | F-Tax Withholding | 126 | $3.94 | $496 | Filing |
| 2026-09-10 | Cobo Marc | officer: principal accounting officer | F-Tax Withholding | 203 | $5.52 | $1K | Filing |
| 2026-09-10 | Cobo Marc | officer: principal accounting officer | A-Grant/Award | 9,038 | $— | $0 | Filing |
| 2026-07-01 | Chen Bihua | director | J-J | 1,704,862 | $— | $0 | Filing |
| 2026-07-01 | Chen Bihua | director | J-J | 4,528,186 | $— | $0 | Filing |
| 2026-07-01 | Chen Bihua | director | J-J | 2,692,459 | $— | $0 | Filing |
| 2026-07-01 | Chen Bihua | director | J-J | 130,865 | $— | $0 | Filing |
| 2026-07-01 | Cobo Marc | officer: principal accounting officer | F-Tax Withholding | 125 | $7.80 | $975 | Filing |
| 2026-07-01 | Elmelech Idan | officer: coo & principal financial ofcr | F-Tax Withholding | 343 | $7.80 | $3K | Filing |
| 2026-07-01 | Ben Yong | officer: chief med & dev officer | F-Tax Withholding | 1,047 | $7.80 | $8K | Filing |
| 2026-07-01 | Beltran Pedro | officer: president and ceo | F-Tax Withholding | 1,047 | $7.80 | $8K | Filing |
| 2026-04-01 | Beltran Pedro | officer: president and ceo | F-Tax Withholding | 1,047 | $9.03 | $9K | Filing |
| 2026-04-01 | Mehra Uneek | other | F-Tax Withholding | 524 | $9.03 | $5K | Filing |
| 2026-04-01 | Ben Yong | officer: chief med & dev officer | F-Tax Withholding | 1,047 | $9.03 | $9K | Filing |
| 2026-03-10 | Ben Yong | officer: chief med & dev officer | A-Grant/Award | 46,670 | $— | $0 | Filing |
| 2026-03-10 | Beltran Pedro | officer: chief scientific officer | A-Grant/Award | 46,670 | $— | $0 | Filing |
| 2026-03-10 | Mehra Uneek | officer: chief financial officer | A-Grant/Award | 23,330 | $— | $0 | Filing |
| 2025-10-10 | BridgeBio Pharma LLC | 10% owner | J-Other | 784,720 | $— | $0 | Filing |
| 2025-10-10 | BridgeBio Pharma, Inc. | 10% owner | J-Other | 784,720 | $— | $0 | Filing |
| 2025-08-11 | Chen Bihua | director | A-Grant/Award | 1,905,046 | $— | $0 | Filing |
| 2025-08-11 | Chen Bihua | director | A-Grant/Award | 5,598,425 | $10.72 | $60.0M | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
0 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| No institutional holdings found | |||||